{
  "ptid_time": "114_S_6595_2018-11-16",
  "img_path": "/data/qiuhui/data/adni/images/114_S_6595/2018-11-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 62,852 mm³, 63.2% above the reference mean. With a Z-score of 1.51 (93.5th percentile), this represents moderate enlargement; hippocampal volume measures 6,428 mm³, 15.0% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; whole brain volume measures 978,824 mm³, 9.3% below the reference mean. With a Z-score of -1.21 (11.3th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,925 mm³, 4.3% below the reference mean. With a Z-score of -0.29 (38.6th percentile), this represents normal volume ; fusiform gyrus volume measures 18,610 mm³, 1.2% below the reference mean. With a Z-score of -0.10 (45.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,276 mm³, 14.4% below the reference mean. With a Z-score of -1.29 (9.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 79.6 years. Gender is Male. Education: 14 years. MMSE: 21.0. MoCA: 7.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.66 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The patient shows moderate ventricular enlargement and mild atrophy in the hippocampus, whole brain, and middle temporal gyrus, which are consistent with neurodegenerative changes. The profoundly elevated AV45 (amyloid PET) and low MMSE/MoCA scores strongly suggest significant cognitive impairment.  \n\nDiagnosis: **Dementia** (likely Alzheimer’s disease given amyloid positivity and hippocampal atrophy, despite APOE4 negativity)  \nConfidence: **High**",
  "timestamp": "2025-07-26T11:50:44.090010"
}